Pharmaceutically acceptable salts of psilocin and uses thereof
US11680043B2 · kind B2 · utility
4Cited by
7References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 30, 2022 |
| Grant date | Jun 20, 2023 |
| Priority date | — |
| Expiry date | Mar 30, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C63/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention composition features pharmaceutically acceptable salts of psilocin and compositions thereof. The pharmaceutically acceptable salts of psilocin may be used to treat a disease or condition, such as a neurological injury, an inflammatory condition, chronic pain, or a psychological condition, in a subject in need thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.